Document ID: chunk:federal_register_of_legislation:F2022C00912:reg:9:p2
Version: federal_register_of_legislation:F2022C00912
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 7415–10467

tuberculosis disease is defined in the Schedule 1 - Dictionary.
(17)      having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the three months before the clinical onset of deep vein thrombosis;
            Note: SARS-CoV-2 is the virus which causes coronavirus disease 2019 (COVID-19).
(18)      having an autoimmune disease at the time of the clinical onset of deep vein thrombosis;
            Note: Examples of autoimmune diseases that may cause deep vein thrombosis include rheumatoid arthritis, polymyositis and Sjögren syndrome.
(19)      having diabetes mellitus at the time of the clinical onset of deep vein thrombosis;
(20)      having a hypercoagulable state as specified at the time of the clinical onset of deep vein thrombosis;
            Note: hypercoagulable state as specified is defined in the Schedule 1 - Dictionary.
(21)      having a kidney disease from the specified list of kidney diseases at the time of the clinical onset of deep vein thrombosis;
            Note: specified list of kidney diseases is defined in the Schedule 1 - Dictionary.
(22)      having a device implanted within the affected vein for a continuous period of at least 24 hours within the six months before the clinical onset of deep vein thrombosis;
            Note: Examples of implanted devices include a central venous catheter, an indwelling cardiac pacemaker and defibrillator leads.
(23)      having surgery requiring a general, spinal or epidural anaesthetic within the six months before the clinical onset of deep vein thrombosis;
(24)      having an injury or illness as specified within the six months before the clinical onset of deep vein thrombosis;
            Note: injury or illness as specified is defined in the Schedule 1 - Dictionary.
(25)      having restricted mobility for a continuous period of at least four hours within the eight weeks before the clinical onset of deep vein thrombosis;
            Note: Examples of situations in which restricted mobility can occur include travel by road, rail or air and physical restraint.
(26)      having a neurological disease that causes loss or impairment of motor function of a limb within the three months before the clinical onset of deep vein thrombosis;
            Note: Examples of neurological diseases that cause loss or impairment of motor function of a limb include cerebrovascular accident, multiple sclerosis and motor neurone disease.
(27)      having a clinically significant disorder of mental health as specified at the time of the clinical onset of deep vein thrombosis;
            Note: clinically significant disorder of mental health as specified is defined in the Schedule 1 - Dictionary.
(28)      taking a drug from the specified list of drugs within the three months before the clinical onset of deep vein thrombosis;
            Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(29)      taking combined estrogen-progestogen contraception or taking menopausal hormone therapy as an oral estrogen,